Clinical trial · Interventional
Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease
A Randomized Clinical Trial of Excision Versus Photodynamic Therapy in Bowen's Disease
NCT00472706CI-TRIAL-00003434terminatedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study stopped because of disappointing inclusion rates
Summary
Brief summary (as posted)
The purpose of this study is to identify the most optimal therapy for Bowen's disease: excision versus Photodynamic therapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bowen's Disease | Squamous Cell Carcinoma In Situ | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| excision | Procedure | — | UNRESOLVED |
| Photodynamic therapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- 1
- description
- Excision
- interventionNames
- Procedure: excision
- type
- ACTIVE_COMPARATOR
- label
- 2
- description
- Photodynamic therapy
- interventionNames
- Procedure: Photodynamic therapy
Primary outcomes (1)
- measure
- recurrence rate
- timeFrame
- two years
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 years * Histological proven Bowen's disease on scalp, face, trunk, arms and legs * Informed Consent Exclusion Criteria: * Recurrent Bowen's disease * Anogenital or subungual Bowe's disease * Other skin malignancy in the same area * Porphyria
References
Publications (0)
Data not yet available
No reference posted for this study.